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ABSTRACT
NAADP (nicotinic acid adenine dinucleotide phosphate) has been proposed as a 
second messenger for glutamate in neuronal and glial cells via the activation of the 
lysosomal Ca2+ channels TPC1 and TPC2. However, the activities of glutamate that are 
mediated by NAADP remain unclear. In this study, we evaluated the effect of glutamate 
on autophagy in astrocytes at physiological, non-toxic concentration. We found that 
glutamate induces autophagy at similar extent as NAADP. By contrast, the NAADP 
antagonist NED-19 or SiRNA-mediated inhibition of TPC1/2 decreases autophagy 
induced by glutamate, confirming a role for NAADP in this pathway. The involvement of 
TPC1/2 in glutamate-induced autophagy was also confirmed in SHSY5Y neuroblastoma 
cells. Finally, we show that glutamate leads to a NAADP-dependent activation of AMPK, 
which is required for autophagy induction, while mTOR activity is not affected by this 
treatment. Taken together, our results indicate that glutamate stimulates autophagy 
via NAADP/TPC/AMPK axis, providing new insights of how Ca2+ signalling glutamate-
mediated can control the cell metabolism in the central nervous system. 
INTRODUCTION
Macroautophagy (here after referred as autophagy) 
is the process by which damaged or superfluous 
intracellular constituents are engulfed in double-membrane 
vesicles, named autophagosomes, and delivered to the 
lysosomes for degradation and recycling [1, 2].
Autophagosomes arise from phosphatidylinositol-
3-phosphate-rich microdomains (omegasomes) generated 
by the Beclin 1/VPS34 complex, mainly located on 
the endoplasmic reticulum [3]. LC3 (microtubule 
associated protein 1A/1B light chain 3) family proteins 
label autophagosomes, playing an essential role both 
in vesicle elongation/closure and cargo recognition. 
In low autophagy conditions, LC3 is diffused in the 
cytosol (LC3-I isoform), while, following autophagy 
induction, LC3 is covalently modified by the addition of a 
phosphatidylethanolamine (LC3-II isoform), which allows 
its translocation to the autophagosome membrane where it 
remains associated until fusion to lysosomes [4, 5].
Acidification is an important step in the activation of 
lysosomal enzymes, which allows to generate functional 
autolysosomes and to promote a complete degradation 
of autophagic substrates [5, 6]. The lysosomal pH is 
maintained at around pH 4.5 by proton pumps that transport 
H+ ions into lysosomes [4]. The inhibition of lysosomal 
activity results in the accumulation of “undigested” 
lipidated LC3-II. To discriminate between increased 
autophagosome formation and reduced lysosomal 
activity, LC3II has to be analysed by comparing the 
levels in the untreated cells with respect to the one treated 
with lysosomal  inhibitors (e.g. E64d and Pepstain A) 
to measure the rate of autophagosome degradation also 
defined as autophagic flux [4].
Research Paper
Oncotarget12731www.impactjournals.com/oncotarget
Ca2+ signalling have a crucial role in many aspects 
of lysosomal function [7–9]. An increase of cytosolic 
Ca2+ is necessary for the fusion of lysosomes to different 
types of vesicles, including phagosomes, late endosomes, 
and autophagosomes [10–16], as well as with the plasma 
membrane [17]. Furthermore, membrane trafficking 
during endocytosis and autophagy involves many fusion 
and fission events that are regulated by Ca2+ [11, 18]. 
Interestingly, lysosomes are also Ca2+ storage 
organelles, and their relevance in intracellular signalling is 
now gaining attention [19]. Indeed, the Ca2+ concentration 
in lysosomes is high and is partially dependent on the H+ 
gradient [17]. Recently, was identified a vertebrate Ca2+/
H+ exchanger (CAX), located at acidic compartments, 
widespread expressed, evoking Ca2+signals, and 
regulating cell-matrix adhesion during cell migration 
[20]. Importantly, a family of Ca2+ channels, known as 
the two-pore channels (TPCs), have emerged as potential 
regulators of Ca2+ homeostasis [21]. The TPCs localise 
at endosomes and/or lysosomes through an identified 
targeting motif and regulate NAADP-mediated cytosolic 
Ca2+ signals [11, 21–23]. In fact, the inhibition of TPC 
expression/function using siRNA [23], knockout mice 
[24], and dominant-negative TPC constructs [22], 
reduces NAADP-evoked Ca2+ signals. Recently, a role for 
NAADP/TPC signalling in the regulation of autophagy 
has been identified. NAADP can induce autophagy in 
astrocytes [11], whereas treatments disturbing TPC-
mediated Ca2+ release in mouse embryonic fibroblasts 
lead to a reduction of autophagy [25]. By contrast, TPC2 
overexpression may cause a block of autophagosome-
lysosome fusion in HeLa cells by preventing the 
recruitment of Rab-7 to autophagosomes [26].
Interestingly, a recent report described the agonist-
specific recruitment of NAADP-sensitive Ca2+stores by 
glutamate; however, the molecular mechanisms underlying 
this event are still not known [27]. To gain insights on this 
signalling pathway, we investigated the effect of glutamate 
on autophagy and its crosstalk with the NAADP/Ca2+ 
signalling pathway, focusing on the role of the lysosomal 
Ca2+-permeable two-pore channels (TPCs).
RESULTS
Glutamate induces autophagic flux via NAADP
We have previously shown that NAADP treatment 
induces autophagy by mobilizing Ca2+ from acidic Ca2+ 
stores through TPCs. Since NAADP has been proposed as a 
second messenger for glutamate [27], we asked if glutamate 
might modulate autophagy via NAADP signalling. 
Modulation of autophagic flux by glutamate was 
analysed in immortalized rat astrocytes and SHSY5Y 
neuroblastoma cells, in comparison with NAADP. Cells 
were treated with 10 µM glutamate or 100 nM NAADP-
AM, in the presence or absence of the lysosome inhibitors 
E64d/pepstatin A, and analysed by western blotting using 
an anti-LC3 antibody. Similar to NAADP, glutamate 
induced autophagy flux, as demonstrated by the increase 
of LC3-II signals in the presence of lysosomal inhibitors 
in astrocytes (Figure 1A–1B).
To provide additional evidence for the ability of 
glutamate to induce autophagy in astrocytes, we used a 
stable cell line expressing a fluorescent-tagged mCherry-
LC3 [28]. Treatment with glutamate (10 µM) or NAADP-
AM (100 nM) for 2 h resulted in an increase of red 
fluorescent puncta, confirming the formation of LC3 
positive vesicles (Figure 1C).
To elucidate if NAADP is involved in the induction 
of autophagy by glutamate, we first confirmed that 
glutamate induces a release of Ca2+ in a NAADP-
dependent manner in astrocytes. To this aim, Fluo-4-
loaded cells were treated with glutamate in the presence 
or absence of the TPC antagonist NED-19. As shown in 
Figure 2A, Ca2+ mobilization by glutamate is dependent 
on NAADP-regulated channels.
We then evaluated the effect of NED-19 on 
glutamate induced autophagy. As shown in Figure 2B, pre-
treatment treatment of cells with NED-19 did not result in 
an increase in LC3-II basal levels, and no further increase 
was observed in the presence of glutamate, indicating 
that autophagy induction by glutamate is inhibited in the 
presence of NED-19. Inhibition of basal autophagy flux by 
NED-19, independently of glutamate stimulation, was also 
confirmed by treating cells with NED-19 in the presence 
or absence of lysosome inhibitors (Figure 2C). 
Taken together, these results indicate that glutamate 
activate autophagy via NAADP.
Glutamate induces autophagy through TPCs
Emerging studies implicate TPCs as candidate 
targets for NAADP within the endolysosomal system 
[8, 11, 21, 22, 24, 29]. To elucidate the role of TPCs 
in the induction of autophagy by glutamate, TPC1 or 
TPC2 was silenced in astrocytes (Figure 3A–3C) and in 
SHSY5Y cells (Supplementary Figure 1A, 1B). For the 
both, TPCs silencing were confirmed by quantitative PCR 
selective knockdown of TPC1 or TPC2 transcripts in 
siRNA-cells. These cells were then treated with glutamate 
(10 µM) for 1 or 2 h in the presence or absence of E64d/
pepstatin A. Notably, TPC downregulation prevented the 
increase of autophagic flux induced by glutamate both 
in astrocytes and SHSY5Y cells, as demonstrated by the 
reduced increase of LC3-II levels after 2 h of glutamate 
in the scramble and silenced cells treated with lysosomal 
inhibitors. According to previous reports, we also observed 
that TPC2 silencing results in higher basal autophagy 
flux, suggesting that in absence of glutamate TPC2 might 
inhibit autophagy. Taken together, these results indicate 
that glutamate induces autophagy through activation of the 
NAADP-sensitive Ca2+ channels TPC1 and TPC2.
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Glutamate activates the upstream autophagy 
regulator AMPK
Since AMP-activated protein kinase (AMPK) 
is known to play an important role in the regulation of 
Ca2+ stimulated autophagy [30], we evaluated the effects 
of NAADP-mediated glutamate signaling on AMPK 
activity. As shown in Figure 4A, glutamate increased the 
phosphorylation of both AMPK and its target ACC. 
We also monitored if glutamate affects the mTOR 
pathway, another important upstream regulator of 
autophagy, by measuring the phosphorylation levels of its 
Figure 1: Glutamate and NAADP induce autophagy in astrocytes. LC3 was detected by western blotting in cells treated with 
glutamate (10 μM) (A), NAADP-AM (100 nM) (B) in the presence or absence of the lysosomal inhibitors E64d/pepstatin A (10 μg/mL, 1 h) 
at the indicated time for 1, 2, and 4 h for each treatment. Samples were subjected to western blotting using anti-LC3 and anti-GAPDH 
antibodies. Representative images of LC3-II are shown (left panel). Graph (right panel) reports means ± s.e.m. of LC3-II levels after 
GAPDH normalization from three independent experiments; *p ˂ 0.05, **p ˂ 0.01. LC3-II levels in control cells were set as 100. 
(C) Autophagosomes numbers were analysed in astrocytes expressing Cherry-LC3 incubated with NAADP-AM (100 nM) or glutamate (10 μM) 
for 2 h, by counting the number of mCherry puncta per cell (graph, lower panel). Representative fluorescent images are shown (upper 
panels, scale bars, 20 μm). At least 40 cells were included for each group. *p < 0.05 in relation to ctrl group (one way ANOVA, followed 
by Dunnett post-test).
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targets p70S6 kinase and ULK1. As shown in Figure  4B, 
glutamate did not inhibit p70S6 kinase and ULK1 
serine 757 phosphorylation, suggesting that it activates 
autophagy in an mTOR-independent manner. 
In agreement with a role of NAADP in autophagy 
regulation by glutamate, we observed that NAADP 
treatment induces AMPK phosphorylation, while no effect 
was observed on the mTOR target p70S6K (Figure 4C).
We then asked if AMPK activation by glutamate is 
mediated by NAADP. To this aim, we analysed the effect 
of glutamate on AMPK phosphorylation levels in cells 
pre-treated with NED-19. Importantly, NED-19 attenuated 
the changes in AMPK activity mediated by glutamate 
(Figure 4D), confirming the important role of NAADP in 
glutamate-regulated signalling.
DISCUSSION 
Glutamate is an excitatory neurotransmitter of the 
central nervous system with a major role in the complex 
Figure 2: NED-19 inhibits Ca2+ release and autophagy induction by glutamate. (A) Cytosolic Ca2+ responses of individual Fluo-
4-loaded cells stimulated with 10 μM with glutamate (10 μM) with our without preincubation with NED-19 (1 μM, 30 min). Representative 
data are shown on the left panel (dark line: Glutamate treated cells in absence of NED-19; grey line: glutamate treated cells in presence 
of NED-19). Right panel: summary data quantifying the amplitude of the Ca2+ signals in the indicated cells. Data are expressed as mean 
± s.e.m. All data are from at least 3 different experiments. ***p < 0.001. (B) LC3 level was detected by western blotting in astrocytes treated 
with glutamate (10 μM) in the presence or absence of NED-19 (1 μM). Samples were subjected to western blotting using anti-LC3 and anti-
GAPDH antibodies. Representative images of LC3-II are shown (left panels).Graph (right panel) reports means ± s.e.m. of LC3-II levels 
after GAPDH normalization from three independent experiments; *p ˂ 0.05, ***p ˂ 0.001. LC3-II levels in control cells were set as 100. 
(C) LC3 level was detected by western blotting in astrocytes treated with NED-19 (1 μM) for 1, 2, and 4 h in the presence or absence of 
the lysosomal inhibitors E64d/pepstatin A (10 μg/mL, added 1 h before lysis). Samples were subjected to western blotting using anti-LC3 
and anti-GAPDH antibodies. Representative images of LC3-II are shown (left panels). Graph (right panel) reports means ± s.e.m. of LC3-II 
levels after GAPDH normalization from three independent experiments. (One way ANOVA, followed by Tukey post-test).
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communication network between neurons, astrocytes, 
oligodendrocytes, and microglia. For example, astrocytes 
release glutamate to regulate synaptic functions in the 
CNS [31–35]. 
Since glutamate acts by modulating a plethora of 
signaling pathways, the alteration of which affects many 
physiological brain functions. The objective of this study 
was to determine the mechanism by which glutamate 
modulates autophagy, a major determinant of protein 
turnover and energy source in neural cells [36]. Previous 
data showed that in astrocytes, glutamate increases the 
endogenous levels of NAADP, which evokes the release 
of Ca2+ from acidic stores [27]. Moreover, when externally 
applied, cell-permeable NAADP mobilizes Ca2+ from 
endolysosomes and regulates autophagy by activating 
TPCs [11]. As recently revised [15], several studies have 
been related the TPCs functionality to different roles in 
disease, highlighting the regulation of endolysosomal 
membrane traffic by local Ca2+ flux. The present study 
now provides compelling evidence that the excitatory 
neurotransmitter glutamate induces autophagy via 
NAADP and the release of Ca2+ from lysosomes either in 
astrocytes or in neuroblastoma cells. 
The results show that glutamate used at a low 
physiological concentration (10 µM) evokes the 
autophagic process in astrocytes and SHSY5Y cells. 
Because this concentration of glutamate does not induce 
toxicity and cell death, it is conceivable that the induced 
Figure 3: Glutamate induces autophagy through TPC1 and 2 activation. The autophagic flux was evaluated in astrocytes 
upon downregulation of TPC1 or TPC2 using the specific siRNA oligonucleotide (siTPC1, siTPC2) in relation to control cells transfected 
with scramble oligonucleotide. (A) Analysis of TPC1 and TPC2 levels upon transfection of specific siRNA by real-time PCR. (B–C) LC3 
level in astrocytes was detected by western blotting in TPC1 (B) or TPC2 (C) silenced cells treated with glutamate (10 μM) for 1, 2, 4 h 
in the presence or absence of the lysosomal inhibitors E64d/pepstatin A (10 μg/mL, added 1 h before lysis). Samples were subjected to 
western blotting using anti-LC3 and anti-GAPDH antibodies. Representative images of LC3-II are shown (upper panels). Graph (lower 
panel) reports means ± s.e.m. of LC3-II levels after GAPDH normalization from three independent experiments; *p ˂ 0.05. LC3-II levels 
in control cells were set as 100. (One way ANOVA, followed by Tukey post-test).
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autophagy is related to the physiological function of this 
neurotransmitter [37].
Autophagy is important for neuronal and glial 
homeostasis and its deficiency in dopaminergic neurons 
results in increased  size of axon profiles, which alters 
the presynaptic structure and neurotransmission, for 
example [36]. This indicates that physiological and 
stimulatory conditions lead to autophagy induction, 
which may act selectively to remove damaged organelles 
in a cytoprotective process [36, 37]. Glutamate is also 
a metabolic substrate, and particularly in astrocytes it 
exerts a critical role in energy production, by recycling 
the excessive glutamate released in synaptic cleft and 
converting to α-ketoglutarate and ammonia [38] therefore, 
in both neurons and glia, it is a source of energy, which 
is important for the storage of neurotransmitters as well 
as brain function [35]. In other systems such as liver and 
pancreas, the gain-of-function mutation in glutamate 
dehydrogenase (GDH) cause the hyperinsulinism/
hyperammonemia (HI/HA) syndrome [39]. It was 
demonstrated that hyperammonemia can increase the 
autophagy markers such as beclin-1, LC3II and p62 and 
Figure 4: Role of AMPK and mTORC1 pathways in autophagy induction by glutamate. Astrocytes were treated with 
glutamate (10 μM) for 1, 2, 4, 6, and 8 h. Protein extracts were subjected to western blotting analyses using antibodies for phospho-
Thr172 AMPK, total AMPK, phospho-Ser79 ACC, total ACC (panel A), phospho-S757 ULK1, total ULK1, phospho-Thr389 p70S6K, 
total p70S6K (panel B). The expression was normalised using anti-GAPDH antibodies. (C) Astrocytes were treated with NAADP (100 nM) 
for 1, 2, 4, 6, and 8 h. Protein extracts were subjected to western blotting analyses using antibodies for phospho-Thr172 AMPK, total 
AMPK, phospho-Thr389 p70S6K, total p70S6K. (D) Astrocytes were treated with glutamate (10 μM) and NED-19 (1 μM), singly or in 
combination, for 1, 2, 4 h. Protein extracts were subjected to western blotting analyses using phospho-Thr172 AMPK, total AMPK and 
LC3. GAPDH was also analysed as a loading control. Representative images of phospho-Thr172 AMPK and total AMPK are shown (upper 
panels). Graph (lower panel) reports means ± s.e.m. of phospho-Thr172 AMPK levels after total AMPK and GAPDH normalization from 
three independent experiments; *p ˂ 0.05. Phospho-Thr172 AMPK levels in control cells were set as 100. (One way ANOVA, followed 
by Tukey post-test).
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contributes to muscle loss in sarcopenia with cirrhosis 
condition [40]. By contrast, a high concentration of 
glutamate leads progressively to cell death by apoptosis or 
other death mechanisms [41, 42]. Indeed, overstimulation 
of N-methyl-D-aspartate (NMDA) receptors by glutamate 
can produce massive Ca2+ entry, which is taken up by 
mitochondria and leads to excitotoxicity [43]. NMDA 
overactivation may contribute to altered Ca2+ homeostasis 
in neurodegenerative diseases [42, 44, 45]. The data 
reported in this study indicate that a low concentration of 
glutamate stimulates autophagy and acts as a pro-survival 
mechanism under physiological conditions. In fact, we 
demonstrated that TPC1 or TPC2 downregulation impairs 
the increase of lipidated LC3 upon glutamate treatment. 
This indicates that both TPC1 and TPC2 activation are 
important for glutamate signalling and stimulation of 
autophagosome formation. These data are consistent with 
previous reports showing that inhibition of the TPC2/
NAADP/Ca2+ pathway impairs basal autophagy in HeLa 
cells and TPCN2–/– mice [26]. 
In this study, we also investigated the mechanism by 
which Ca2+ release from lysosomes induced by NAADP 
modulates autophagy flux. Our data indicate that the 
AMPK/ACC pathway is stimulated by both glutamate and 
NAADP, whereas NED-19 abrogates this activation. 
AMPK is a crucial modulator of the autophagic 
process in response to energy deprivation and changes 
in Ca2+ levels. AMPK can induce autophagy by acting 
via two different pathways, directly, by phosphorylating 
the proautophagic factor ULK1 [46, 47], and indirectly, 
by negatively regulating the mTOR complex targeting 
them TOR inhibitors tuberous sclerosis complex 1 and 2 
(TSC1/2) and the mTOR activator Rheb, a Ras homologue 
GTP binding protein enriched in the brain [30, 43, 49]. In 
our system, the AMPK-dependent activation of autophagy 
by glutamate appears to act in a mTOR-independent 
manner, because the phosphorylation of its targets 
p70S6K1 and serine 757 ULK1 were found unchanged. 
This is consistent with studies performed in highly 
metabolic cells, such as skeletal muscle, in which 
activation of autophagy by AMPK occurs without 
interfering with the pleiotropic function of mTOR required 
to sustain physiological activities. It was reported that 
AMPK activation affects glutamate metabolism in 
tricarboxylic acid (TCA) cycle in astrocytes [50], which 
may have implications in energy availability in CNS. 
Together, these results suggest that AMPK is an important 
sensor for maintaining glutamatergic neurotransmission by 
modulating autophagy.
In conclusion, the present findings support a novel 
physiological role for glutamate, which, via NAADP-
mediated TPCs activation, leads to the release of lysosomal 
Ca2+, and AMPK-dependent autophagy induction. In light 
of these results, we propose that the glutamate/NAADP-
induced autophagy signalling is a promising pathway for 
targeting in metabolic processes in the SNC.
MATERIALS AND METHODS
Drugs
NAADP-AM and NED-19 were synthesised as 
previously described [51, 52]. Glutamate, E64d, pepstatin 
A and G418 were purchased from Sigma-Aldrich 
Chemical Co., St Louis, MO, USA.
Cell culture
Astrocytes were immortalized as described 
previously [53]; briefly, the primary astrocytes from rat 
cortex were transfected with 3 µg of pSV3-neo, a plasmid 
containing the SV40 T antigen and the neomycin resistance 
gene. SHSY5Y cells were cultured in DMEM (Sigma-
Aldrich) supplemented with 10% FBS (Life Technologies), 
2 mM L-glutamine, and 1% penicillin/streptomycin 
solution at 37°C under 5% CO2. Lysosome activity 
was inhibited with E64d and pepstatin A (10 µg/mL). 
The plasmids short hairpin pSUPER + GFP vector, GFP-
Scramble GFP-shTPC1 or GFP-shTPC2 were obtained 
as previously cloned (Oligoengine) [21]. SHSY5Y cells 
were transfected with each plasmid (2 µg/mL) using 
Lipofectamine LTX (Life Technologies) and according 
to the manufacturer’s instructions. Transfected cells were 
then selected with 0.4 mg/mL G418 for 1 month.
Plasmids and retroviral infection
The myc-tagged, full-length wild-type TPC1 and 
TPC2 constructs were kindly provided by Sandip Patel 
(UCL, London, UK) and cloned into a modified version 
of the pLPCX vector (Clontech) [54]. The LC3 construct 
mCherry-LC3B was previously described [55]. For virus 
production, 15 μg retroviral vector as co-transfected with 
5 μg expression plasmid for the vesicular stomatitis virus 
G protein into the 293 gp/bsr cell line using the calcium 
phosphate method. After 48 h, the supernatant containing 
the retroviral particles was recovered and supplemented 
with 4 μg/mL polybrene and stored at –80°C. 
Antibodies
The primary antibodies used in this study were as 
follows: the rabbit antibodies anti-LC3B, phospho-Ser79 
ACC, total ACC, phospho-Thr172 AMPK, total AMPK, 
phospho-Thr389 p70S6K, total p70S6K and phospho-
serin757 ULK1 (Cell Signaling); anti-ULK1 (Santa Cruz 
Biotechnology); anti-TPC1 and TPC2 (Abcam); anti-
GAPDH (Calbiochem); anti-β-actin (Sigma-Aldrich).
RNA interference
RNA interference in astrocytes was performed 
using the following RNA oligonucleotide duplexes 
from Life Technologies: TPCN1 and TPCN2. A total of 
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1.0 × 105 cells/well were transfected with 20 nmol siRNA 
oligonucleotides in 6-well plates using Lipofectamine 
RNAiMAX (Life Technologies) following the supplier’s 
instructions. For rat astrocytes, the sequences for each 
transcript were TPCN1 forward (5′-GGAUCCUAGUGGA 
GACAUUTT-3′) and reverse (5′-AAUGUCUCCACUAG 
GAUCCAG-3′); TPCN2 forward (5′-GGAAACCUCUU 
GUAUUUTT-3′) and reverse (5′-AAAUAGACAAGAG 
GUUUCCCA-3′); Gene silencing was verified by real-
time PCR analysis 48 h after transfection.
Confocal microscopy 
Autophagic flux was measured in the mCherry-
LC3B stable cell line. Astrocytes expressing Cherry-LC3 
were grown on a coverslip, treated with different 
conditions and fixed with 4% paraformaldehyde for 
15 min in PBS. The coverslips were mounted with antifade 
(SlowFade; Life Technologies) and examined under a 
confocal microscope (TCS SP2; Leica). The results report 
the number of LC3 puncta per cell. For quantification 
of red (Cherry) mCherry-LC3 (td-tag-LC3) puncta, 
pictures were captured at 60× magnification on a confocal 
microscope, and the number of red puncta analysed as 
described above from (30–40) randomly selected cells per 
experiment and condition.
Western blotting assays
Cells for each different experimental protocol 
were lysed in RIPA (150 mM NaCl, 1% NP-40, 0.5% 
deoxycholic acid, 0.1% SDS, 50 mM Tris pH 8.0, and 
2 mM MgCl2). Protease and phosphatase inhibitors 
(protease inhibitor cocktail plus 5 mM sodium fluoride, 
0.5 mM sodium orthovanadate, 1 mM sodium molybdate, 
50 mM 2-chloroacetamide, 2 mM 1,10-phenanthroline 
monohydrate, and 0,5 mM PMSF; Sigma-Aldrich) 
were added. Lysates were incubated at 4°C for 30 min. 
After centrifugation at 4°C for 10 min at 13,000 rpm 
to remove insoluble debris, the protein concentrations 
were determined using a Bradford assay with bovine 
serum albumin as the reference standard (Biorad). Equal 
amounts of protein (10 µg) were re-suspended in SDS-
PAGE sample buffer. The samples were then separated 
on NuPAGE Bis-Tris gel (Life Technologies) and 
electroblotted onto nitrocellulose (Protran, Schleicher 
& Schuell) or PVDF (Millipore) membranes. Blots 
were incubated with primary antibody in 5% non-fat 
dry milk in PBS plus 0.1% Tween-20 overnight at 4°C. 
Detection was achieved using a horseradish peroxidase-
conjugate secondary antibody (Jackson Immuno Research 
Laboratories) and visualised with ECL (GE Healthcare).
Ca2+ measurements
Astrocytes were plated on coverslips and incubated 
with 3 µM Fluo-4AM (Molecular Probes, Eugene, OR, 
USA) for 30 minutes in a microscopy buffer containing 
(in mM): 130 NaCl, 5.36 KCl, 0.8 MgSO4, 1 Na2HPO4, 
25 glucose, 20 HEPES, pH 7.3. Fluo-4 AM fluorescence 
was acquired at 3 s intervals with alternate excitation 
at 494 nm and emission at 506 nm. Using an inverted 
fluorescence microscope Nikon TE 300; Nikon, Osaka, 
Japan) coupled to a CCD camera (CoolSnap, Princeton 
Instruments, Princeton, NJ). Images were analyzed with 
BioIP software (Anderson Eng, Delaware, USA).
Real Time PCR 
RNA was extracted by using Trizol reagent 
(Invitrogen). cDNA synthesis was generated using a 
reverse transcription kit (Promega) according to the 
manufacturer’s recommendations. Quantitative PCR 
reactions were performed with the Rotor-Gene 6000 
(Corbett Research Ltd) thermocycler. The Maxima SYBR 
Green/ROX qPCR Master Mix (Thermo Scientific) was 
used to produce fluorescently labeled PCR products. 
Primer sets for all amplicons were designed using the 
Primer-Express 1.0 software system (Roche): For SHSY5Y 
were used: human TPC1 forward (5′-TCCGGATGGAA 
CTTGTTTG-3′) and reverse (5′-GCAGGACCACGA 
TGAAATAG-3′); human TPC2 forward (5′-TGGTGGAC 
TGTCGGTATT-3′) and reverse (5′-AAACCGAGGATG 
GCAAAG-3′); human GAPDH forward (5′-CGCTTCGCT 
CTCTGCTCCT-3′) and reverse (5′-CCGTTGACTCCG 
ACCTTCAC-3′). The oligonucleotide primer sequences to 
TPCs from rat astrocytes were described previously [21].
Statistical analysis
All values are represented as the mean ± s.e.m. 
Significance was tested by ANOVA followed by Dunnett 
test for comparisons with the experiment control. Multiple 
comparisons among group mean differences were assessed 
with Tukey post-test. Differences were considered 
significant when p < 0.05.
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